XSHE300272
Market cap445mUSD
Jan 09, Last price
5.78CNY
1D
-1.53%
1Q
-1.53%
Jan 2017
-31.78%
IPO
24.21%
Name
Canature Health Technology Group Co Ltd
Chart & Performance
Profile
Canature Health Technology Co., Ltd. engages in the research, development, manufacture, production of residential water treatment products in China, the Middle East, Europe, rest of Asia, North America, and internationally. Its products include whole-house water purifiers and softeners, commercial purified water dispensers, membrane reverse osmosis water purifiers, multi-way control valves, and composite pressure vessels. The company was formerly known as Shanghai Canature Environmental Products Co., Ltd. and changed its name to Canature Health Technology Co., Ltd. in July 2018. Canature Health Technology Co., Ltd. was founded in 2001 and is headquartered in Shanghai, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 1,671,699 0.67% | 1,660,642 9.87% | |||||||
Cost of revenue | 1,235,332 | 1,347,913 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 436,367 | 312,730 | |||||||
NOPBT Margin | 26.10% | 18.83% | |||||||
Operating Taxes | 5,328 | 14,847 | |||||||
Tax Rate | 1.22% | 4.75% | |||||||
NOPAT | 431,040 | 297,883 | |||||||
Net income | 132,447 43.09% | 92,562 -11.73% | |||||||
Dividends | (78,155) | (56,717) | |||||||
Dividend yield | 2.19% | 1.94% | |||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
Debt | |||||||||
Debt current | 703,665 | 523,420 | |||||||
Long-term debt | 261,027 | 167,038 | |||||||
Deferred revenue | 24,509 | 18,773 | |||||||
Other long-term liabilities | 143,889 | 137,104 | |||||||
Net debt | (825,303) | (332,062) | |||||||
Cash flow | |||||||||
Cash from operating activities | 374,830 | 155,435 | |||||||
CAPEX | (80,238) | ||||||||
Cash from investing activities | (349,674) | ||||||||
Cash from financing activities | 430,288 | 30,983 | |||||||
FCF | 569,935 | 262,378 | |||||||
Balance | |||||||||
Cash | 894,883 | 413,099 | |||||||
Long term investments | 895,111 | 609,421 | |||||||
Excess cash | 1,706,410 | 939,488 | |||||||
Stockholders' equity | 1,371,724 | 1,162,187 | |||||||
Invested Capital | 1,093,127 | 918,732 | |||||||
ROIC | 42.85% | 32.64% | |||||||
ROCE | 17.16% | 16.32% | |||||||
EV | |||||||||
Common stock shares outstanding | 575,855 | 561,705 | |||||||
Price | 6.20 19.00% | 5.21 -27.54% | |||||||
Market cap | 3,570,302 22.00% | 2,926,482 -28.24% | |||||||
EV | 2,817,368 | 2,621,627 | |||||||
EBITDA | 515,594 | 388,489 | |||||||
EV/EBITDA | 5.46 | 6.75 | |||||||
Interest | 32,583 | 16,845 | |||||||
Interest/NOPBT | 7.47% | 5.39% |